1. India Stocks

  2. •

    Industrials

  3. •

    Manufacturing - Miscellaneous
CCME Global Ltd

CCME Global Ltd

GENESIS.BO
CCME Global LtdIN flagBombay Stock Exchange
118.70
INR
-2.85
- -
1.54BMarket Cap
CCME Global Ltd
GENESIS.BO
(Bombay Stock Exchange)

Recent

price

118.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
0.76
0.46
0.75
1.28
1.09
- -
0.07
0.25
0.04
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
1.85
-2.17
-0.85
-1.1
-0.62
0.44
- -
-0.17
-0.04
-0.08
-0.09
-0.09
-0.11
-2.92
2.7
- -
-0.33
Basic EPS, GAAP
0.09
-0.07
-0.44
0.02
-6.83
-3.37
-0.25
1.46
-3.61
0.01
-0.09
-0.09
-0.07
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-8.93
-11.54
-12.44
-13.48
-0.59
3.26
2.81
4.89
4.2
4.12
4.03
3.94
3.84
0.91
3.62
- -
20.75
Book Value per Share
3.35
1.17
0.33
-0.77
4.81
8.16
6.65
8.22
7.15
7.07
6.98
6.89
6.79
3.87
6.57
- -
18.38
Tangible Book Value per Share
3
3
3
3
7
8
10
11
13
13
13
13
13
13
13
- -
22
Basic Weighted Avg Shares
2
1
2
4
8
- -
1
3
1
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-255.07
-462.75
-214.21
-85.63
-46.2
- -
2.18
-67.5
-105.24
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
3
2
2
2
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
6
-7
-3
-3
-4
3
- -
-2
-1
-1
-1
-1
-1
-38
35
-7
-7
Net Income, GAAP
- -
- -
- -
- -
- -
- -
18.75
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
244.76
-475.22
-113.63
-85.63
-57.22
- -
1.77
-67.55
-105.38
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-10
-11
-12
-13
34
64
67
48
93
92
91
90
88
50
85
401
401
Working Capital
11
- -
- -
- -
- -
- -
- -
4
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
10
4
1
-2
34
64
67
95
93
92
91
90
88
50
85
401
401
Total Equity
-9.7
- -
- -
- -
- -
6.75
0.02
- -
- -
- -
- -
- -
- -
- -
-2.39
- -
- -
Return on Invested Capital (%)
26.8
- -
- -
- -
- -
27.66
0.05
- -
- -
- -
- -
- -
- -
- -
119.16
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
0.05
-4.64
-0.99
-1.93
-2.19
-2.25
-2.72
-122.99
119.16
-2.86
-2.86
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
- -
45
Market Capitalization
989
1,234
2,158

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
85
- -
453
Cash, Cash Equivalents & STI
1
- -
374
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
- -
52
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.57%
78.69%
369.59%
Free Cash Flow
-170,501.89%
-340,352.52%
-1,701,566.67%
Net Income, GAAP
-1,285.47%
473.86%
-120.39%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
-0.02
-0.02
- -
-2.92
2025
-0.07
2.81
-0.02
-0.02
2.7
2026
-0.09
-0.05
-0.02
-0.11
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Felix Industries Ltd. (FELIX.NS)
Shaily Engineering Plastics Limited (SHAILY.BO)
Rasi Electrodes Limited (RASIELEC.BO)
Rimoni Industries Ltd. (RIMO.TA)
Mitsu Chem Plast Ltd (MITSU.BO)
Vamshi Rubber Limited (VAMSHIRU.BO)
Business
Genesis IBRC India Ltd is an integrated bio research and resource center primarily engaged in manufacturing and supplying sustainable solutions across aqua, poultry, veterinary, and agriculture sectors. The company offers a comprehensive product portfolio including microbial and antimicrobial products tailored for disease prevention, productivity enhancement, and cost reduction in aquaculture, poultry, and veterinary applications. Its core products include probiotics, aqua health supplements, soil probiotics, veterinary formulations, and agricultural bioinputs. The company also provides research and development services, consulting, and contract manufacturing for over 40 companies. Founded in 2011 and headquartered in Vijayawada, India, Genesis IBRC has expanded geographically with operations and distribution networks in Bangladesh, Thailand, Vietnam, UAE, Singapore, Brazil, and other global markets. Recent developments include strategic push towards global collaborations and strengthening its R&D capabilities, with continued emphasis on innovative ecofriendly microbial solutions and a focus on building international relationships. In 2025, Genesis IBRC underwent notable shareholding changes involving significant stake transactions and continues to report active engagement in board meetings and financial reporting, underscoring ongoing efforts to enhance corporate governance and operational transparency. The company remains committed to advancing organic and sustainable farming practices through its cellular input technologies and ecofriendly product innovations.